On May 16, 2017, approximately 99 percent of Theranos shareholders reached an agreement with the company to dismiss all current and potential litigation in exchange for shares of preferred stock.
2017年5月16日，約99%的Theranos股東和公司和解，願意撤回所有当前和潜在的诉讼，換取優先股的股份。